LEADER 05481oam 2200469 450 001 9910483567203321 005 20210626121205.0 010 $a3-030-57915-8 024 7 $a10.1007/978-3-030-57915-9 035 $a(CKB)4900000000508947 035 $a(DE-He213)978-3-030-57915-9 035 $a(MiAaPQ)EBC6468496 035 $a(PPN)253861144 035 $a(EXLCZ)994900000000508947 100 $a20210626d2021 uy 0 101 0 $aeng 135 $aurnn|008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aManagement of muscle invasive bladder cancer /$fSanchia S. Goonewardene [and five others] 205 $a1st ed. 2021. 210 1$aCham, Switzerland :$cSpringer,$d[2021] 210 4$d©2021 215 $a1 online resource (XXXIX, 590 p. 37 illus. in color.) 225 0 $aManagement of urology 300 $aIncludes index. 311 $a3-030-57914-X 327 $a1. Introduction to muscle invasive bladder cancer -- 2. Epidemiology and risk factors in muscle invasive bladder cancer -- 3. The molecular basis of muscle invasive bladder cancer -- 4. Histological variants in MIBC - squamous cell and squamous differentiation -- 5. Histological variants in muscle invasive bladder cancer ? adenocarcinoma -- 6. Histological variants in muscle invasive bladder Cancer - sarcomatoid cancer -- 7. MIBC Carcinosarcoma -- 8. Muscle invasive bladder cancer- small cell -- 9. MIBC plasmacytoid -- 10. MIBC and micropapillary bladder cancer -- 11. MIBC bladder cancer assessment and diagnosis -- 12. A systematic review on blue light cystoscopy in bladder cancer diagnostics -- 13. A systematic review on the staging conundrum in bladder cancer -- 14. Current state of investigations and limitations in muscle invasive bladder cancer -- 15. Risk stratification in bladder cancer -- 16. Preventative measures for those with high risk MIBC -- 17. Bladder cancer risk post pelvic irradiation -- 18. A systematic review on bladder preservation strategies and MIBC -- 19. Partial cystectomy -- 20. Muscle invasive bladder cancer and neoadjuvant chemotherapy -- 21. Controversies in clinical effectiveness of neoadjuvant chemotherapy -- 22. Trimodal therapy in bladder cancer -- 23. Systematic review on trimodal therapy in bladder cancer -- 24. Trimodal therapy - a systematic review -- 25. Reviews related to trimodal therapy for MIBC -- 26. Radical cystectomy lap open robotic -- 27. Prostate sparing cystectomy - a systematic review -- 28. A systematic review on nerve sparing cystoprostatectomy -- 29. MIBC - orthotopic vs ileal conduit -- 30. MIBC - a systematic review on orthotopic neobladder vs. ileal conduit -- 31. MIBC and radical cystectomy in the elderly -- 32. MIBC radical radiotherapy -- 33. MIBC - quality of life with urinary diversion -- 34. Neoadjuvant chemotherapy for muscle invasive bladder cancer -- 35. Muscle invasive bladder cancer and the staging conundrum -- 36. Radical cystectomy outcomes -- 37. Muscle Invasive bladder cancer and neoadjuvant chemotherapy -- 38. Muscle invasive bladder cancer and the staging conundrum -- 39. Physical pre-habilitation prior to radical cystectomy -- 40. Exercise therapy pre surgery -- 41. Patient fitness for surgery -- 42. CPEX testing prior to major urological surgery -- 43. Cardio-pulmonary exercise testing and major urological surgery -- 44. Robotic radical cystectomy and enhanced recovery -- 45. The robotic approach to redo surgery -- 46. Robotic cystectomy and intracorporeal neobladder formation -- 47. Secondary pelvic malignancies and bladder cancer -- 48. Organ sparing cystectomy -- 49. Robotic radical cystectomy -- 50. Robotic cystectomy and intracorporeal stoma formation -- 51. Orthotopic neobladders vs. ileal conduits -- 52. The role of enhanced recovery in robotic cystectomy -- 53. Robotic radical cystectomy and lymph node dissection -- 54. Robotic cystectomy and sentinel node mapping -- 55. Robotic radical cystectomy and intracorporeal stoma formation -- 56. Lap vs open vs robotic cystectomy -- 57. A systematic review on obesity in bladder cancer -- 58. Systematic review results on obesity in bladder cancer -- 59. Reviews on BMI and bladder cancer -- 60. Survivorship Issues in muscle invasive bladder cancer -- 61. Muscle invasive bladder cancer and health related quality of life -- 62. Body image in bladder cancer -- 63. The rationale for neoadjuvant chemotherapy -- 64. Support for partners in bladder cancer. 330 $aThis book provides a systematic review of the management and treatment of this disease. The concise and highly structured chapters feature essential background knowledge and commentary on recent advances within each step of a range of patient pathways. Management of Muscle Invasive Bladder Cancer provides a framework for patients? care based on the research, as well as practically and clinically oriented guidelines. This book is relevant to trainees and practicing urologists and oncologists, in addition to medical professionals involved in the treatment of bladder cancer. 410 0$aManagement of Urology,$x2730-6372 606 $aBladder$xCancer 615 0$aBladder$xCancer. 676 $a616.99462 700 $aGoonewardene$b Sanchia$01228004 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bUtOrBLW 906 $aBOOK 912 $a9910483567203321 996 $aManagement of muscle invasive bladder cancer$92850997 997 $aUNINA